Healthcare data’s moment of lift
The unlocking of patient data is leading us to a future when health care will be a vastly improved experience with superior outcomes. However, there will be guard rails around consumer access to personal health records.
Data wants to be free. Data also wants to be in free markets.
A slew of newly announced initiatives points to the inexorable shift of data away from walled gardens and tightly controlled environments into the world of free markets. Consider these:
- A group of healthcare institutions and technology providers has launched an open-source initiative titled CommonHealth to let Android-powered device users gain access to medical records. The initiative will dramatically increase the number of consumers who will have access to their medical records, essentially replicating Apple’s remarkably successful efforts to give iOS users access to health records from over a hundred participating hospitals and health systems.
- Allscripts, a health IT company, has opened up access to their Electronic Health Records (EHR) system to Apple, enabling patients from hospitals using the Allscripts platform to access their records over their iOS devices such as iPhones.
- Epic has launched a massive healthcare data compilation effort entitled Cosmos to aggregate over 20 million patient medical records from providers in a participation agreement designed to make the data pool available for analysis in improving care decisions.
OK, I’m not so sure about the last one, but you get the drift. Patient medical information is being set free so that their rightful owners, i.e., consumers, can access and share them freely. ET go home. At last.
So, all is good, right? Maybe, maybe not…
The ONC, while supporting the idea of allowing consumers unfettered access to their medical information, has also rung a warning bell against unregulated use of the healthcare data by third-party apps. Several medical associations have also raised the alarm about potential invasions of privacy arising from patients unwittingly granting access to their healthcare data to third parties. They have highlighted likely undesirable effects, including the possibility of misuse of the data by insurance companies, employers, and others who may use the information to discriminate against consumers. These are valid concerns. Those of us who willingly signed away our data rights to big tech firms who in turn unwittingly handed them off to malicious actors (recall Facebook and Cambridge Analytica) will appreciate the need to slow down and ensure there are adequate guard rails to protect against misuse of personal medical information.
Indeed, the horse may have already left the barn. Those among us who voluntarily uploaded our DNA data on open platforms have compromised not just ourselves but our extended families as well. For every Golden State killer that was nailed by a relative’s DNA data, there are likely some anonymous souls who have been targeted inappropriately due to their identities being compromised by a relative’s online DNA record.
Even arrangements where consumers do not gain access to their data may benefit them in indirect ways. Epic’s Cosmos program may spur medical research that leads to breakthrough insights for improved care. Allscripts’s data-sharing agreement with Apple unlocks hitherto inaccessible data from the EHR system and hands it to consumers. The many industry collaborations underway, such as the recently announced partnership between Mayo Clinic and Google, could result in breakthroughs in clinical insights that could benefit the broader population. The ONC’s TEFCA initiative – if it becomes law – will significantly enhance healthcare innovation and improvements in quality of care by enabling free flow of patient data across the nation.
The one thing missing in all of these efforts is clarity on the degree of control consumers can exercise on how their data will be used in all these arrangements. In that sense, we are not in a free market for patient medical data, certainly not one where the consumer not only decides whom to share it with but also how much to charge for access to the healthcare data. But then, maybe we are not ready for a free market for patient data, and perhaps we will never be. This may not be entirely a bad thing, as long as the emerging data-sharing arrangements bring about improvements in patient experience and care quality while reducing costs of care.
The unlocking of patient data is leading us to a future when health care will be delivered at a time, place, and mode of the consumer’s choosing. That day, to paraphrase Melinda Gates, would the Moment of Lift. Like in the iconic ’80s movie, ET has just barely got on the bike. We are rooting for him to lift off. He will. Hopefully soon.